JACN Did you know that you can get alerts when a new issue is online?
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Heaney, R. P.
Right arrow Articles by Bendich, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Heaney, R. P.
Right arrow Articles by Bendich, A.
Journal of the American College of Nutrition, Vol. 20, No. 3, 239-246 (2001)
Published by the American College of Nutrition

Original Research

Absorbability and Cost Effectiveness in Calcium Supplementation

Robert P. Heaney, MD, M. Susan Dowell, PhD, June Bierman, BSMT, Cecilia A. Hale, PhD and Adrianne Bendich, PhD

Creighton University, Osteoporosis Research Center, Omaha, Nebraska (R.P.H., M.S.D., J.B.), GlaxoSmithKline, Parsippany, New Jersey (C.A.H., A.B.)
Creighton University, Osteoporosis Research Center, GlaxoSmithKline, Parsippany, New Jersey (C.A.H., A.B.)

Address reprint requests to: Robert P. Heaney, MD, Creighton University, Osteoporosis Research Center, 601 North 30th Street—Suite 4841, Omaha, NE 68131. E-mail: rheaney{at}creighton.edu

Background: Cost-effectiveness of calcium supplementation depends not only on the cost of the product but on the efficiency of its absorption. Published cost-benefit analyses assume equal bioavailability for all calcium sources. Some published studies have suggested that there are differences in both the bioavailability and cost of the major calcium supplements.

Design: Randomized four period, three-way cross-over comparing single doses of off-the-shelf commercial calcium supplements containing either calcium carbonate or calcium citrate compared with a no-load blank and with encapsulated calcium carbonate devoid of other ingredients; subjects rendered fully vitamin D-replete with 10 µg/day 25(OH)D by mouth, starting one week prior to the first test.

Subjects: 24 postmenopausal women

Methods: Pharmacokinetic analysis of the increment in serum total and ionized calcium and the decrement in serum iPTH induced by an oral calcium load, based upon multiple blood samples over a 24-hour period; measurement of the rise in urine calcium excretion. Data analyzed by repeated measures ANOVA. Cost calculations based on average retail prices of marketed products used in this study from April through October, 2000.

Results: All three calcium sources (marketed calcium carbonate, encapsulated calcium carbonate and marketed calcium citrate) produced identical 24-hour time courses for the increment in total serum calcium. Thus, these were equally absorbed and had equivalent bioavailability. Urine calcium rose slightly more with the citrate than with the carbonate preparations, but the difference was not significant. Serum iPTH showed the expected depression accompanying the rise in serum calcium, and there were no significant differences between products.

Conclusion: Given the equivalent bioavailability of the two marketed products, the cost benefit analysis favors the less expensive carbonate product.

Key words: calcium absorption, calcium carbonate, calcium citrate, bioavailability, cost-effectiveness






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American College of Nutrition.